No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
APLT250117P5000
- 4.10
- +0.30+7.89%
15min DelayClose Dec 20 16:00 ET
4.15High4.10Low
4.15Open3.80Pre Close4 Volume5.03K Open Interest5.00Strike Price1.65KTurnover395.77%IV-2.27%PremiumJan 17, 2025Expiry Date4.12Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8787Delta0.2401Gamma0.21Leverage Ratio-0.0033Theta-0.0018Rho-0.19Eff Leverage0.0005Vega
Intraday
- 5D
- Daily
News
William Blair Downgrades Applied Therapeutics to Market Perform
William Blair Downgrades Applied Therapeutics(APLT.US) to Hold Rating
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Cuts Target Price to $1.5
Applied Therapeutics Is Maintained at Sector Perform by RBC Capital
Applied Therapeutics Analyst Ratings
Applied Therapeutics CEO Shendelman Steps Down